The immunogenetics of asthma and eczema: A new focus on the epithelium

Nature Reviews Immunology

Volumn 4, Issue 12, 2004, Pages 978-988

  Cookson, William ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; INTERLEUKIN 13; PROTEIN S 100; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR;

ASTHMA; ATOPIC DERMATITIS; ATOPY; AUTOIMMUNE DISEASE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE PREDISPOSITION; ECZEMA; EPITHELIUM CELL; GENE EXPRESSION; GENE LOCUS; GENETIC LINKAGE; HUMAN; IMMUNOGENETICS; INFLAMMATION; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN DISEASE; STRATUM CORNEUM; TH1 CELL; TH2 CELL;

ANIMALS; ASTHMA; ECZEMA; EPITHELIUM; HUMANS; RESPIRATORY MUCOSA;

EID: 10244250341     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1500     Document Type: Review

References (141)

1. Johansson, S. G. et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 56, 813-824 (2001). This paper describes an overview of the history of atopic disease and its classification, and addresses many of the problems in understanding and classifying the incomplete overlap between atopy, asthma and AD.
2. von Pirquet, C. Allergie. Munch med Wochenschr 30, 1457-1458 (1906).
3. Noon, L. Prophylactic innoculation against hay-fever. Lancet i, 1572-1573 (1911).
4. Turner, H. & Kinet, J. P. Signalling through the high-affinity IgE receptor FcεRI. Nature 402, B24-B30 (1999).
5. Kay, A. B. Allergy and allergic diseases. Second of two parts. N. Engl. J. Med. 344, 109-113 (2001).
6. Kay, A. B. Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344, 30-37 (2001). References 5 and 6 give an excellent overview of current understanding of atopic diseases.
7. Crater, S. E. & Platts-Mills, T. A. Searching for the cause of the increase in asthma. Curr. Opin. Pediatr. 10, 594-599 (1998).
8. Koenig, J. Air pollution and asthma. J. Allergy Clin. Immunol. 104, 717-722 (1999).
9. Strachan, D. P. Hay fever, hygiene, and household size. Brit. Med. J. 299, 1259-1260 (1989). This paper is the first to use the term 'hygiene hypothesis'.
10. von Mutius, E. et al. Prevalence of asthma and atopy in two areas of West and East Germany. Am. J. Respir. Crit. Care Med. 149, 358-364 (1994). This landmark paper was the first to recognize that the prevalence of atopy is altered by the environment: in this case polluted East Germany contained less atopy than the unpolluted West
11. Holt, P.G., Macaubas, C., Stumbles, P.A. & Sly, P. D. The role of allergy in the development of asthma. Nature 402, B12-B17 (1999).
12. H2 balance could be altered by the neonatal environment
13. Romagnani, S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 112, 352-363 (2004).
14. Cox, H. E. et al. Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor. Br. J. Dermatol. 138, 182-187 (1998).
15. Creticos, P. S. et al. Ragweed immunotherapy in adult asthma. N. Engl. J. Med. 334, 501-506 (1996).
16. Adkinson, N. F. Jr et al. A controlled trial of immunotherapy for asthma in allergic children. N. Engl. J. Med. 336, 324-331 (1997).
17. Barnes, P. J. Is immunotherapy for asthma worthwhile? N. Engl. J. Med. 334, 531-532 (1996).
18. Holgate, S. T. et al. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin. Exp. Allergy 34, 632-638 (2004).
19. Farrall, M. Quantitative genetic variation: a post-modern view. Hum. Mol. Genet. 13, R1-R7 (2004).
20. Duffy, D. L., Martin, N. G., Battistutta, D., Hopper, J. L. & Mathews, J. D. Genetics of asthma and hay fever in Australian twins. Am. Rev. Respir. Dis. 142, 1351-1358 (1990).
21. Larsen, F. S., Holm, N. V. & Henningsen, K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J. Am. Acad. Dermatol. 15, 487-494 (1986).
22. Schultz Larsen, F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J. Am. Acad. Dermatol. 28, 719-723 (1993).
23. Cookson, W. A new gene for asthma: would you ADAM and Eve it? Trends Genet. 19, 169-172 (2003).
24. Wills-Karp, M. & Ewart, S. L. Time to draw breath: asthma-susceptibility genes are identified. Nature Rev Genet. 5, 376-387 (2004). This paper contains a comprehensive review of the current state of asthma genetics, including reference to murine models of disease.
25. Becker, K. et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl Acad. Sci. USA 95, 9979-9984 (1998). This paper was the first to observe clustering of inflammatory disease loci in a limited number of chromosomal segments.
26. Cookson, W. Genetics and genomics of asthma and allergic diseases. Immunol. Rev. 190, 195-206 (2002).
27. Bowcock, A. M. & Cookson, W. O. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum. Mol. Genet. 13, R43-55 (2004). This paper contains a review of the genetics of AD.
28. Tosh, K. et al. A region of chromosome 20 is linked to leprosy susceptibility in a South Indian population. J. Infect. Dis. 186, 1190-1193 (2002).
29. Judge, M. R., Morgan, G. & Harper, J. I. A clinical and immunological study of Netherton's syndrome. Br. J. Dermatol. 131, 615-621 (1994).
30. Bitoun, E. et al. Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J. Invest. Dermatol. 118, 352-361 (2002).
31. Chavanas, S. et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nature Genet. 25, 141-142 (2000).
32. Mägert, H. J. et al. LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J. Biol. Chem. 274, 21499-21502 (1999).
33. Walley, A. J. et al. Gene polymorphism in Netherton and common atopic disease. Nature Genet. 29, 175-178 (2001).
34. Nishio, Y. et al. Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese. Genes Immun. 4, 515-517 (2003).
35. Kato, A. et al. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br. J. Dermatol. 148, 665-669 (2003).
36. Kabesch, M., Carr, D., Weiland, S. K. & von Mutius, E. Association between polymorphisms in serine protease inhibitor, kazal type 5 and asthma phenotypes in a large German population sample. Clin. Exp. Allergy 34, 340-345 (2004).
37. Komatsu, N. et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J. Invest. Dermatol. 118, 436-443 (2002).
38. Leyden, J. J., Marples, R. R. & Kligman, A. M. Staphylococcus aureus in the lesions of atopic dermatitis. Br. J. Dermatol. 90, 525-530 (1974).
39. Christophers, E. & Henseler, T. Contrasting disease patterns in psoriasis and atopic dermatitis. Arch. Dermatol. Res. 279 (Suppl.), S48-S51 (1987).
40. Miedzobrodzki, J., Kaszycki, P., Bialecka, A. & Kasprowicz, A. Proteolytic activity of Staphylococcus aureus strains isolated from the colonized skin of patients with acute-phase atopic dermatitis. Eur. J. Clin. Microbiol. Infect. Dis. 21, 269-276 (2002). This paper shows that the S. aureus that are associated with AD have high levels of protease activity.
41. Winton, H. L. et al. Class specific inhibition of house dust mite proteinases which cleave cell adhesion, induce cell death and which increase the permeability of lung epithelium. Br. J. Pharmacol. 124, 1048-1059 (1998).
42. Wachter, A. M. & Lezdey, J. Treatment of atopic dermatitis with α1-proteinase inhibitor. Ann. Allergy 69, 407-414 (1992).
43. Cookson, W. O. et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nature Genet. 27, 372-373 (2001).
44. Capon, F. et al. Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J. Invest. Dermatol. 112, 32-35 (1999).
45. Mischke, D., Korge, B. P., Marenholz, I., Volz, A. & Ziegler, A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ('epidermal differentiation complex') on human chromosome 1q21. J. Invest. Dermatol. 106, 989-992 (1996).
46. Nomura, I. et al. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J. Allergy Clin. Immunol. 112, 1195-1202 (2003).
47. Bowcock, A. M. et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum. Mol. Genet. 10, 1793-1805 (2001).
48. Zhou, X. et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63, 100-element oligonucleotide array. Physiol. Genomics 13, 69-78 (2003).
49. Marshall, D., Hardman, M. J., Nield, K. M. & Byrne, C. Differentially expressed late constituents of the epidermal cornified envelope. Proc. Natl Acad. Sci. USA 98, 13031-13036 (2001).
50. Lohman, F. et al. Expression of the SPRR cornification genes is differentially affected by carcinogenic transformation. Exp. Cell Res. 231, 141-148 (1997).
51. Hardas, B. et al. Assignment of psoriasin to human chromosomal band 1q21: coordinate overexpression of clustered genes in psoriasis. J. Invest. Dermatol. 106, 753-758 (1996).
52. Christiano, A. M. Frontiers in keratodermas: pushing the envelope. Trends Genet. 13, 227-233 (1997).
53. Donate, R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668 (2001).
54. Allen, M. et al. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nature Genet. 35, 258-263 (2003).
55. Laitinen, T. et al. Characterization of a common susceptibility locus for asthma-related traits. Science 304, 300-304 (2004).
56. Zhang, Y. et al. Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma. Nature Genet. 34, 181-186 (2003).
57. Van Eerdewegh, P. et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418, 426-430 (2002).
58. Kuperman, D. A. et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nature Med. 8, 885-889 (2002).
59. Ober, C. et al. Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am. J. Hum. Genet. 66, 517-526 (2000).
60. Donnadieu, E. et al. Competing functions encoded in the allergy-associated FcεRIβ gene. Immunity 18, 665-674 (2003).
61. Traherne, J. A. et al. LD mapping of maternally and non-maternally derived alleles and atopy in FcεRI-β. Hum. Mol. Genet. 12, 2577-2585 (2003).
62. Oguma, T. et al. Role of prostanoid DP receptor variants in susceptibility to asthma. N. Engl. J. Med. 351, 1752-1763 (2004).
63. Baldini, M. et al. A polymorphism* in the 57prime; flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell Mol. Biol. 20, 976-983 (1999).
64. Eder, W. et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J. Allergy Clin. Immunol. 113 ,482-488 (2004).
65. Kabesch, M. et al. Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. J. Allergy Clin. Immunol. 111, 813-817 (2003).
66. McIntire, J. J. et al. Immunology: hepatitis A virus link to atopic disease. Nature 425, 576 (2003).
67. Raby, B. A. et al. Polymorphisms in toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am. J. Respir. Crit. Care Med. 166, 1449-1456 (2002).
68. Noguchi, E. et al. An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin. Exp. Allergy 34, 177-183 (2004).
69. Lazarus, R. et al. TOLL-like receptor 10 genetic variation is associated with asthma in two independent samples. Am. J. Respir. Crit. Care Med. 170, 594-600 (2004).
70. Moffatt, M. F. & Cookson, W. O. Tumour necrosis factor haplotypes and asthma. Hum. Mol. Genet. 6, 551-554 (1997).
71. Pulleyn, L. J., Newton, R., Adcock, I. M. & Barnes, P. J. TGFβ1 allele association with asthma severity. Hum. Genet. 109, 623-627 (2001).
72. Hewett, D. et al. Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map. Genomes 79, 305-314 (2002).
73. Tiilikainen, A., Lassus, A., Karvonen, J., Vartiainen, P. & Julin, M. Psoriasis and HLA-Cw6. Brit. J. Dermatol. 102, 179-184 (1980).
74. Ahnini, R. T. et al. Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis. Hum. Mol. Genet. 8, 1135-1140 (1999).
75. Asumalahti, K. et al. A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele. Hum. Mol. Genet. 9, 1533-1542 (2000).
76. Allen, M. et al. Corneodesmosin expression in psoriasis vulgaris differs from normal skin and other inflammatory skin disorders. Lab. Invest 81, 969-976 (2001).
77. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
78. Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
79. Stoll, M. et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nature Genet. 36, 476-480 (2004).
80. Peltekova, V. D. et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nature Genet. 36, 471-475 (2004).
81. Lala, S. et al. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 125, 47-57 (2003).
82. Hisamatsu, T. et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterolgy 124, 993-1000 (2003).
83. Kamada, F. et al. Association of the hCLCA1 gene with childhood and adult asthma. Genes Immun. (2004).
84. Hegab, A. E. et al. CLCA1 gene polymorphisms in chronic obstructive pulmonary disease. J. Med. Genet. 41, e27 (2004).
85. Tomic-Canic, M., Komine, M., Freedberg, I. M. & Blumenberg, M. Epidermal signal transduction and transcription factor activation in activated keratinocytes. J. Dermatol. Sci. 17,167-181 (1998).
86. Freedberg, I., Tomic-Canic, M., Komine, M. & Blumenberg, M. Keratins and the keratinocyte activation cycle. J. Invest. Dermatol. 116, 633-640 (2001).
87. Song, P. I. et al. Human keratinocytes express functional CD14 and Toll-like receptor 4. J. Invest. Dermatol. 119, 424-432 (2002).
88. Muir, A. et al. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 30, 777-783 (2004).
89. Ichikawa, J. K. et al. Interaction of pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs. Proc. Natl Acad. Sci. USA 97, 9659-9664 (2000).
90. Belcher, C. E. et al. The transcriptional responses of respiratory epithelial cells to Bordetella pertussis reveal host defensive and pathogen counter-defensive strategies. Proc. Natl Acad. Sci. USA 97, 13847-13852 (2000).
91. Clauss, A., Lilja, H. & Lundwall, A. A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein. Biochem. J. 368, 233-242 (2002).
92. Simpson, A. J., Maxwell, A. I., Govan, J. R., Haslett, C. & Sallenave, J. M. Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positwe and gram-negative respiratory pathogens. FEBS Lett. 452, 309-313 (1999).
93. Singh, P. K., Tack, B. F., McCray, P. B. Jr & Welsh, M. J. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung. Cell. Mol. Physiol. 279, L799-805 (2000).
94. Tomee, J. F., Koeter, G. H., Hiemstra, P. S. & Kauffman, H. F. Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option? Thorax 53, 114-116 (1998).
95. Bals, R. et al. Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. 102, 874-880 (1998).
96. Bals, R., Wang, X., Zasloff, M. & Wilson, J. M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl Acad. Sci. USA 95, 9541-9546 (1998).
97. Huttner, K. M. & Bevins, C. L. Antimicrobial peptides as mediators of epithelial host defense. Pediatr. Res. 45, 785-794 (1999).
98. Brogan, T. D., Ryley, H. C., Neale, L. & Yassa, J. Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis. Thorax 30, 72-79 (1975).
99. Benson, M. et al. DMA microarrays to study gene expression in allergic airways. Clin. Exp. Allergy 32, 301-308 (2002).
100. Kaufman, H. S. & Hobbs, J. R. Immunoglobulin deficiencies in an atopic population. Lancet 2, 1061-1063 (1970).
101. Ludviksson, B. R., Eiriksson, T. H., Ardal, B., Sigfusson, A. & Valdimarsson, H. Correlation between serum immunoglobulin A concentrations and allergic manifestations in infants. J. Pediatr. 121, 23-27 (1992).
102. Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nature Med. 5, 1249-55 (1999).
103. Matzinger, P. The danger model: a renewed sense of self. Science 296, 301-305 (2002). Matzinger explains that danger signals are essential for the initiation of an immune response.
104. Palaniyar, N., Nadesalingam, J. & Reid, K. B. Pulmonary innate immune proteins and receptors that interact with gram-positive bacterial ligands. Immunobiology 205, 575-594 (2002).
105. Kopp, E. & Medzhitov, R. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15, 396-401 (2003).
106. Inohara, N. & Nunez, G. NODS: Intracellular proteins involved in inflammation and apoptosis. Nature Rev. Immunol. 3, 371-382 (2003).
107. Chamaillard, M., Girardin, S. E., Viala, J. & Philpott, D. J. Nods, Nalps and Naip: Intracellular regulators of bacterial-induced inflammation. Cell. Microbiol. 5, 581-582 (2003).
108. Seong, S. Y. & Matzinger, P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nature Rev. Immunol. 4, 469-478 (2004).
109. Ring, P. C. et al. The 18-kDa form of cat allergen Felis domesticus 1 (Fel d 1) is associated with gelatin- and fibronectin-degrading activity. Clin. Exp. Alergy 30, 1085-1096 (2000).
110. Bufe, A., Schramm, G., Keown, M. B., Sohlaak, M. & Becker, W. M. Major allergen Phl p Vb in timothy grass is a novel pollen RNase. FEBS Lett. 363, 6-12 (1995).
111. Tjabringa, G. S. et al. The antimicrobial peptide LL-37 activates innate immunity at tie airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 171, 6690-6696 (2003).
112. Yang, D., Biragyn, A., Kwak, L. W. & Oppenheim, J. J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23, 291-296 (2002).
113. Yoshio, H. et al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr. Res. 53, 211-216 (2003).
114. Brandtzaeg, P. et al. The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv. Exp. Med. Biol. 371 A, 201-206 (1995).
115. Steinbakk, M. et al. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 336, 763-765 (1990).
116. Miyasaki, K. T., Bodeau, A. L., Murthy, A. R. & Lehrer, R. I. In vitro antimicrobial activity of the human neutrophil cytosolic S-100 protein complex, calprotectin, against Capnocytophaga sputigena. J. Dent. Res. 72, 517-523 (1993).
117. Gottsch, J. D., Eisinger, S. W., Liu, S. H. & Scott, A. L. Calgranulin C has filariacidal and filariastatic activity. Infect. Immun. 67, 6631-6636 (1999).
118. Yang, D. et al. Many chemokines including CCL20/MIP-3α display antimicrobial activity. J. Leukoc. Biol. 74, 448-455 (2003). A review highlighting that many chemokines have antimicrobial activity.
119. Pulendran, B., Palucka, K. & Banchereau, J. Sensing pathogens and tuning immune responses. Science 293, 253-256 (2001). A good review of how specific pathogen recognition alters the nature of the immune response.
120. H1 immunity. J. Exp. Mod. 188, 2019-2031 (1998).
121. Mazzoni, A. & Segal, D. M. Controlling the Toll road to dendritic cell polarization. J. Leukoc. Biol. 75, 721-730 (2004).
122. Rook, G. A. & Stanford, J. L. Give us this day our daily germs. Immunol. Today 19, 113-116 (1998).
123. Bjorksten, B. Effects of intestinal microflora and the environment on the development of asthma and allergy. Springer Semin. Immunopathol. 25, 257-270 (2004).
124. Hooper, L. V. & Gordon, J. I. Commensal host-bacterial relationships in the gut. Science 292, 1115-1118 (2001).
125. Sepp, E. et al. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr. 86, 956-961 (1997).
126. Bjorksten, B., Naaber, P., Sepp, E. & Mikelsaar, M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin. Exp. Allergy 29, 342-346 (1999).
127. Svanes, C., Jarvis, D., Chinn, S. & Bumey, P. Childhood environment and adult atopy: results from the European Community Respiratory Health Survey. J. Allergy Clin. Immunol. 103, 415-420 (1999).
128. Hesselmar, B., Aberg, N., Aberg, B., Eriksson, B. & Bjorksten, B. Does early exposure to cat or dog protect against later allergy development? Clin. Exp. Allergy 29, 611-617 (1999).
129. von Mutius, E. et al. Skin test reactivity and number of siblings. BMJ 308, 692-695 (1994).
130. Riedler, J. et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancer 358, 1129-1133 (2001). This paper describes the strongly protective effect of farm environments and non-pasteurized milk on the prevalence of asthma in Alpine regions.
131. Wickens, K. et al. Farm residence and exposures and the risk of allergic diseases in New Zealand children. Allergy 57, 1171-1179 (2002).
132. Komada, T. et al. Novel specific chemtactic receptor for S100L protein on guinea pig eosinophils. Biochem. Biophys. Res. Commun. 220, 871-874 (1996).
133. Jinquan, T. et al. Psoriasin: a novel chemotactic protein. J. Invest. Dermatol. 107, 5-10 (1996).
134. Passey, R. J., Xu, K., Hume, D. A. & Geczy, C. L. S100A8: emerging functions and regulation. J. Leukoc. Biol. 66, 549-556 (1999).
135. Lackmann, M. et al. Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10. J. Immunol. 150, 2981-2991 (1993).
136. Cornish, C. J. et al. S100 protein CP-10 stimulates myeloid cell chemotaxis without activation. J. Cell. Physiol. 166, 427-437 (1996).
137. Eue, I., Pietz, B., Storck, J., Kiempt, M. & Sorg, C. Transendothelial migration of 27E10* human monocytes. Int. Immunol. 12, 1593-1604 (2000).
138. Yui, S., Mikami, M. & Yamazaki, M. Purification and characterization of the cytotoxic factor in rat peritoneal exudate cells: its identification as the calcium binding protein complex, calprotectin. J. Leukoc. Biol. 58, 307-316 (1995).
139. Aguiar-Passeti, T., Postol, E., Sorg, C. & Mariano, M. Epithelioid cells from foreign-body granutoma selectively express the calcium-binding protein MRP-14, a novel down-regulatory molecule of macrophage activation. J. Leukoc. Biol. 62, 852-858 (1997).
140. Brun, J. G., Ulvestad, E., Fagemol, M. K. & Jonsson, R. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scand. J. Immunol. 40, 675-680 (1994).
141. Hofmann, M. A. et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901 (1999).